oncodaily

To patients and oncologists alike: Are there questions living inside you that you have not been asking out loud? Could it be that you do not even know what questions to ask? Are there answers you have arrived at privately…

When Gloria Chiniere Okwu discovered a lump in her left breast in 2016, she could not have imagined that the diagnosis would eventually make her one of the most influential patient advocates in Nigeria. Today, Gloria is a cancer survivor,…

We often describe progress in oncology through the language of discovery. Scientific breakthroughs. Technological innovation. Deeper biological insight. These advances have transformed medicine, helping millions of people live longer and better than ever before. Yet alongside every scientific breakthrough, a…

Treatment with GLP-1 receptor agonists (GLP-1RAs) was associated with a significantly lower risk of progression to metastatic disease in non–small cell lung cancer (NSCLC), breast cancer, colorectal cancer (CRC), and hepatocellular carcinoma (HCC). The study, presented at the 2026 American…

Twenty-five years after imatinib transformed chronic myeloid leukaemia from a fatal diagnosis into a manageable disease for many patients, Brian Druker reflects on the curiosity, setbacks, and patients who shaped one of oncology's greatest breakthroughs. Long before I understood the…

"Cancer is part of a person's life, but it should never become their entire identity." That simple yet powerful observation from global cancer advocate Carmen Monge-Montero captures a growing recognition in oncology: treating cancer successfully requires more than surgery, chemotherapy,…

Karen Nakawala spent decades telling other people's stories. As one of Zambia's well-known broadcasters, she knew how to command a microphone, connect with audiences and give voice to people whose experiences might otherwise go unheard. Whether presenting a live radio…

Millions of cancer patients live within reach of life saving radiation treatment. Millions more live nowhere near it. The research maps just how wide, and how consequential, that gap has become. Radiotherapy is a cornerstone of modern cancer care. Around…

Daraxonrasib nearly doubled median survival in previously treated metastatic pancreatic cancer. For Dr Eileen O’Reilly, the result is not simply a remarkable curve on a conference screen, but the beginning of a new way to think about a disease long…

Over four decades, Dr Tezer Kutluk, Scientific Director of Medicana Health group and Chair of the Department of Pediatric Oncology at Medicana Hospitals, Turkey, has witnessed the transformation of cancer care—from the early days of pediatric oncology to the era…